AOTI, Inc.
Status: Publicly traded
Direct answer
AOTI, Inc. is publicly traded on LSE under the ticker AOTI.L.
AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System. The company was founded by Michael Stephen Griffiths in 2006 and is headquartered in Oceanside, CA.
Can you invest in AOTI, Inc.?
Yes. AOTI, Inc. trades publicly on LSE as AOTI.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.